The Lisbon Commercial Court holds pharmaceutical companies guilty of 63 breaches on Portuguese competition law (Abbott Laboratórios, Menarini Diagnóscitos and Johnson & Johnson)

The Lisbon Commercial Court, confirming the decision of the Portuguese Competition Authority, held that the undertakings of Abbott Laboratórios Lda., Menarini Diagnóscitos Lda. and Johnson & Johnson Lda. were proven to be guilty of 63 breaches of the Portuguese competition law rules. Briefly, the Competition Authority held that the companies acted together on attempts to increase the prices on public proceedings of purchasing hospital goods, specifically on the purchase of the reagent for determination of glucose in the blood. This product is composed by strips that, together with a specific measurement equipment, allow the determination of the level of glucose in

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Henrique Santos Costa de Souza, The Lisbon Commercial Court holds pharmaceutical companies guilty of 63 breaches on Portuguese competition law (Abbott Laboratórios, Menarini Diagnóscitos and Johnson & Johnson), 7 January 2010, e-Competitions Bulletin Competition in the Pharmaceutical sector, Art. N° 31545

Visites 1603

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues